Why is Vaidya Sane falling/rising?
As of 22-Jul, Vaidya Sane Ayurved Laboratories Ltd's stock price has declined to Rs 176.00, down 2.22%, despite positive returns over the past week and month. The stock is close to its 52-week high but is experiencing reduced investor participation and underperformance relative to its sector.
As of 22-Jul, Vaidya Sane Ayurved Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 176.00, which reflects a decrease of Rs 4.0 or 2.22%. Despite this recent drop, the stock has shown positive performance over the past week and month, with returns of 2.92% and 16.56%, respectively. However, today's performance indicates it has underperformed its sector by 1.31%. The stock is close to its 52-week high, just 3.52% away from Rs 182.2, but there has been a notable decrease in investor participation, with delivery volume falling by 46.67% compared to the 5-day average. The company maintains a strong financial position with a low Debt to EBITDA ratio of 0.38 times and impressive profit growth, which supports a healthy long-term outlook.In the broader market context, the stock's recent performance contrasts with the benchmark, as it has outperformed the Sensex over the past year, generating a return of 17.37% compared to the Sensex's 2.25%. However, the stock's current decline may be influenced by the recent drop in trading volume and underperformance relative to its sector. While the company has demonstrated strong fundamentals and market-beating performance, the recent price movement suggests that short-term market dynamics and reduced investor interest are impacting its stock price.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
